← board
ZOMDF
distress 4/10 · elevated risk$0.090%today-44% from 52w high
Revenue
pre-revenue
Liquidity
$9M
Runway
0.6 yrs
Shares 1y
0%
Price & events
-37.7% over 6M
CatalystRating changeDilutionFinancingdashed = today
+0.0%
1D
-1.1%
1W
-3.4%
1M
-15.7%
3M
-34.8%
6M
+120.5%
1Y
-42.7%
2Y
-86.3%
5Y
-75.4%
All
Overview
- Market Cap
- $84.28M
- Volume
- 8.44K
- 52 Week Range
- $0.04 – $0.15
- Total Shares
- 979.95M
- Float Shares
- 949.44M
- Short %
- 4.71%
- % Held by Insiders
- 2.75%
- % Held by Institutions
- 0.12%
- RVOL
- 0.01x
- Beta
- 1.35
Pipeline · 0 trials · 0 upcoming
| Readout | Phase | Drug | Indication | Enroll | Status |
|---|---|---|---|---|---|
| No pipeline trials tracked. | |||||
Catalyst news & presentations · 1
- 2026-08-06Estimated 45%earningsEarningsEarnings releaseyahoo
Approved drugs (0)
- none — clinical-stage
Capital structure — dilution & financing
Shares out: 979,949,668 · 0 offerings/1y · 0 PIPEs
- 2024-11-198-Kmaterial_agreement
🔒 Top holders — Pro
Institutional ownership + quarter-over-quarter accumulation/trimming.
Upgrade to ProWall St ratings
no consensus
- no recent rating changes
Competitors
- none identified
Recent news
- 2026-07-15Zomedica Announces "Fourth Friday at Four" Webinar on July 24, 2026: Zomedica's Sales Organization - From Strategy to the Clinic - Yahoo Finance
- 2026-07-09Price to earnings forward of Zomedica Corp. – OTC:ZOMDF - TradingView
- 2026-07-02Zomedica (ZOM) Q2 2024 earnings summary - Quartr
- 2026-06-25Zomedica Corp Actuals & Estimates (OTC:ZOMDF) - TradingView
- 2026-06-25Zomedica's Assisi Loop(R) Products Designated "Fear Free(R)" as Alliance to Advance Low Stress Care and Pet Wellbeing Continues with Fear Free, LLC - ACCESS Newswire
- 2026-06-25Zomedica's Assisi Loop gets Fear Free designation for lower-stress pet care - Stock Titan
- 2026-06-21Zomedica (ZOM) Q1 2026 earnings summary - Quartr
- 2026-06-21Zomedica (ZOM) Proxy filing Summary - Quartr
Not financial advice. Data: ClinicalTrials.gov, SEC EDGAR, FINRA, Nasdaq, Yahoo.